Global Sexually Transmitted Diseases Testing Market 2018-2022
About Sexually Transmitted Diseases Testing
STDs, also known as STIs, are infectious diseases caused by bacteria, yeast, parasites, and viruses, and are transmitted through sexual contact, thus generating the need for STD testing and demand for devices used for testing.
Technavio’s analysts forecast the global sexually transmitted diseases testing market to grow at a CAGR of 8.61% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global sexually transmitted diseases testing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Sexually Transmitted Diseases Testing Market 2018-2022
Technavio recognizes the following companies as the key players in the global sexually transmitted diseases testing market: Abbott, bioMerieux, Bio-Rad Laboratories, and F. Hoffmann La Roche.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is high demand for POC testing. The diagnostic sector is undergoing revolutionary changes, with device miniaturization, growth in testing menus, and the introduction of multi-parameter testing devices. Another significant development in this sector is the emergence of POC testing.”
According to the report, one driver in the market is rise in STDs. The rise in STDs has become a global public health challenge. STDs include more than 25-30 infectious diseases that are spread through sexual activity. A person needs to visit a health clinic or hospital for STD testing and treatment if exposed to a sexually transmitted pathogen. Common STDs include chlamydia, syphilis, gonorrhea, herpes, HPV, and HIV infections.
Further, the report states that one challenge in the market is lack of trained professionals. STD testing requires extensive optimization before results can be interpreted correctly. Therefore, clinical laboratories and diagnostic centers require trained specialists. However, there is a global shortage of these specialists in diagnostic centers and hospitals. For instance, most rural hospitals in the US face issues such as low patient volume and are unable to justify the expenses associated with employing specialists who charge high.
Abbott, bioMerieux, Bio-Rad Laboratories, and F. Hoffmann La Roche.